nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—EDNRB—asthma	0.45	1	CbGaD
Bosentan—ABCB11—Dexamethasone—asthma	0.0214	0.0707	CbGbCtD
Bosentan—CYP2C9—Zileuton—asthma	0.0169	0.056	CbGbCtD
Bosentan—CYP2C9—Zafirlukast—asthma	0.0149	0.0493	CbGbCtD
Bosentan—CYP3A4—Fluticasone furoate—asthma	0.0146	0.0482	CbGbCtD
Bosentan—CYP2C9—Formoterol—asthma	0.0144	0.0476	CbGbCtD
Bosentan—CYP2C9—Arformoterol—asthma	0.0144	0.0476	CbGbCtD
Bosentan—CYP3A4—Budesonide—asthma	0.013	0.043	CbGbCtD
Bosentan—CYP3A4—Indacaterol—asthma	0.0119	0.0393	CbGbCtD
Bosentan—CYP3A4—Ciclesonide—asthma	0.0119	0.0393	CbGbCtD
Bosentan—CYP2C9—Theophylline—asthma	0.0115	0.0381	CbGbCtD
Bosentan—CYP3A4—Salbutamol—asthma	0.0111	0.0366	CbGbCtD
Bosentan—CYP3A4—Flunisolide—asthma	0.0111	0.0366	CbGbCtD
Bosentan—CYP3A4—Salmeterol—asthma	0.0111	0.0366	CbGbCtD
Bosentan—CYP2C9—Loratadine—asthma	0.0109	0.0361	CbGbCtD
Bosentan—CYP2C9—Montelukast—asthma	0.0109	0.0361	CbGbCtD
Bosentan—CYP3A4—Zileuton—asthma	0.00985	0.0326	CbGbCtD
Bosentan—CYP3A4—Ipratropium bromide—asthma	0.00985	0.0326	CbGbCtD
Bosentan—CYP3A4—Fluticasone Propionate—asthma	0.0094	0.0311	CbGbCtD
Bosentan—CYP3A4—Zafirlukast—asthma	0.00867	0.0287	CbGbCtD
Bosentan—CYP3A4—Tiotropium—asthma	0.00747	0.0247	CbGbCtD
Bosentan—CYP3A4—Aminophylline—asthma	0.00712	0.0236	CbGbCtD
Bosentan—CYP3A4—Theophylline—asthma	0.0067	0.0221	CbGbCtD
Bosentan—CYP3A4—Montelukast—asthma	0.00635	0.021	CbGbCtD
Bosentan—CYP3A4—Loratadine—asthma	0.00635	0.021	CbGbCtD
Bosentan—CYP3A4—Methylprednisolone—asthma	0.00581	0.0192	CbGbCtD
Bosentan—CYP3A4—Triamcinolone—asthma	0.0044	0.0146	CbGbCtD
Bosentan—CYP2C9—Dexamethasone—asthma	0.00378	0.0125	CbGbCtD
Bosentan—CYP3A4—Betamethasone—asthma	0.00378	0.0125	CbGbCtD
Bosentan—CYP3A4—Prednisolone—asthma	0.00373	0.0123	CbGbCtD
Bosentan—CYP3A4—Hydrocortisone—asthma	0.00353	0.0117	CbGbCtD
Bosentan—CYP3A4—Prednisone—asthma	0.00352	0.0116	CbGbCtD
Bosentan—CYP3A4—Dexamethasone—asthma	0.0022	0.00726	CbGbCtD
Bosentan—EDNRB—adrenal cortex—asthma	0.000851	0.141	CbGeAlD
Bosentan—EDNRB—bronchus—asthma	0.000834	0.139	CbGeAlD
Bosentan—EDNRA—adrenal cortex—asthma	0.000703	0.117	CbGeAlD
Bosentan—EDNRA—bronchus—asthma	0.000689	0.115	CbGeAlD
Bosentan—EDNRA—trachea—asthma	0.000619	0.103	CbGeAlD
Bosentan—EDNRB—adrenal gland—asthma	0.000614	0.102	CbGeAlD
Bosentan—EDNRB—lung—asthma	0.000538	0.0895	CbGeAlD
Bosentan—EDNRA—adrenal gland—asthma	0.000508	0.0844	CbGeAlD
Bosentan—EDNRA—lung—asthma	0.000445	0.074	CbGeAlD
Bosentan—CYP2C9—cardiovascular system—asthma	0.000212	0.0353	CbGeAlD
Bosentan—Angiopathy—Betamethasone—asthma	2.85e-05	0.000187	CcSEcCtD
Bosentan—Angiopathy—Dexamethasone—asthma	2.85e-05	0.000187	CcSEcCtD
Bosentan—Rash—Budesonide—asthma	2.85e-05	0.000187	CcSEcCtD
Bosentan—Dermatitis—Budesonide—asthma	2.85e-05	0.000187	CcSEcCtD
Bosentan—Headache—Budesonide—asthma	2.83e-05	0.000186	CcSEcCtD
Bosentan—Loss of consciousness—Hydrocortisone—asthma	2.82e-05	0.000185	CcSEcCtD
Bosentan—Bradycardia—Prednisone—asthma	2.79e-05	0.000183	CcSEcCtD
Bosentan—Nausea—Salbutamol—asthma	2.77e-05	0.000182	CcSEcCtD
Bosentan—Discomfort—Prednisolone—asthma	2.76e-05	0.000181	CcSEcCtD
Bosentan—Angioedema—Triamcinolone—asthma	2.76e-05	0.000181	CcSEcCtD
Bosentan—Haemoglobin—Prednisone—asthma	2.75e-05	0.000181	CcSEcCtD
Bosentan—Angioedema—Methylprednisolone—asthma	2.75e-05	0.000181	CcSEcCtD
Bosentan—Haemorrhage—Prednisone—asthma	2.74e-05	0.00018	CcSEcCtD
Bosentan—Erythema—Betamethasone—asthma	2.74e-05	0.00018	CcSEcCtD
Bosentan—Erythema—Dexamethasone—asthma	2.74e-05	0.00018	CcSEcCtD
Bosentan—Anxiety—Hydrocortisone—asthma	2.72e-05	0.000179	CcSEcCtD
Bosentan—Vertigo—Triamcinolone—asthma	2.71e-05	0.000178	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	2.71e-05	0.000178	CcSEcCtD
Bosentan—Syncope—Triamcinolone—asthma	2.7e-05	0.000178	CcSEcCtD
Bosentan—Vertigo—Methylprednisolone—asthma	2.7e-05	0.000178	CcSEcCtD
Bosentan—Syncope—Methylprednisolone—asthma	2.7e-05	0.000177	CcSEcCtD
Bosentan—Discomfort—Hydrocortisone—asthma	2.69e-05	0.000177	CcSEcCtD
Bosentan—Nausea—Budesonide—asthma	2.68e-05	0.000176	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisolone—asthma	2.68e-05	0.000176	CcSEcCtD
Bosentan—Oedema—Prednisolone—asthma	2.68e-05	0.000176	CcSEcCtD
Bosentan—Loss of consciousness—Triamcinolone—asthma	2.65e-05	0.000174	CcSEcCtD
Bosentan—Loss of consciousness—Methylprednisolone—asthma	2.64e-05	0.000174	CcSEcCtD
Bosentan—Shock—Prednisolone—asthma	2.63e-05	0.000173	CcSEcCtD
Bosentan—Cough—Triamcinolone—asthma	2.63e-05	0.000173	CcSEcCtD
Bosentan—Anaphylactic shock—Hydrocortisone—asthma	2.61e-05	0.000172	CcSEcCtD
Bosentan—Oedema—Hydrocortisone—asthma	2.61e-05	0.000172	CcSEcCtD
Bosentan—Tachycardia—Prednisolone—asthma	2.61e-05	0.000172	CcSEcCtD
Bosentan—Infection—Hydrocortisone—asthma	2.6e-05	0.000171	CcSEcCtD
Bosentan—Hyperhidrosis—Prednisolone—asthma	2.59e-05	0.00017	CcSEcCtD
Bosentan—Shock—Hydrocortisone—asthma	2.57e-05	0.000169	CcSEcCtD
Bosentan—Nervous system disorder—Hydrocortisone—asthma	2.56e-05	0.000168	CcSEcCtD
Bosentan—Arthralgia—Methylprednisolone—asthma	2.56e-05	0.000168	CcSEcCtD
Bosentan—Eye disorder—Prednisone—asthma	2.56e-05	0.000168	CcSEcCtD
Bosentan—Anxiety—Methylprednisolone—asthma	2.55e-05	0.000168	CcSEcCtD
Bosentan—Tachycardia—Hydrocortisone—asthma	2.55e-05	0.000168	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.54e-05	0.000167	CcSEcCtD
Bosentan—Flushing—Prednisone—asthma	2.54e-05	0.000167	CcSEcCtD
Bosentan—Skin disorder—Hydrocortisone—asthma	2.54e-05	0.000167	CcSEcCtD
Bosentan—Discomfort—Triamcinolone—asthma	2.54e-05	0.000167	CcSEcCtD
Bosentan—Discomfort—Methylprednisolone—asthma	2.53e-05	0.000166	CcSEcCtD
Bosentan—Hyperhidrosis—Hydrocortisone—asthma	2.53e-05	0.000166	CcSEcCtD
Bosentan—Dry mouth—Triamcinolone—asthma	2.51e-05	0.000165	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CMA1—asthma	2.5e-05	0.000279	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VIP—asthma	2.5e-05	0.000279	CbGpPWpGaD
Bosentan—Angioedema—Dexamethasone—asthma	2.5e-05	0.000164	CcSEcCtD
Bosentan—Angioedema—Betamethasone—asthma	2.5e-05	0.000164	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—AGTR1—asthma	2.5e-05	0.000279	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCR3—asthma	2.49e-05	0.000278	CbGpPWpGaD
Bosentan—Anorexia—Hydrocortisone—asthma	2.49e-05	0.000164	CcSEcCtD
Bosentan—Angiopathy—Prednisone—asthma	2.48e-05	0.000163	CcSEcCtD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—asthma	2.48e-05	0.000276	CbGpPWpGaD
Bosentan—Immune system disorder—Prednisone—asthma	2.47e-05	0.000162	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—ITPR1—asthma	2.47e-05	0.000276	CbGpPWpGaD
Bosentan—Anaphylactic shock—Triamcinolone—asthma	2.46e-05	0.000162	CcSEcCtD
Bosentan—Oedema—Triamcinolone—asthma	2.46e-05	0.000162	CcSEcCtD
Bosentan—Vertigo—Dexamethasone—asthma	2.46e-05	0.000162	CcSEcCtD
Bosentan—Vertigo—Betamethasone—asthma	2.46e-05	0.000162	CcSEcCtD
Bosentan—Anaphylactic shock—Methylprednisolone—asthma	2.46e-05	0.000161	CcSEcCtD
Bosentan—Syncope—Dexamethasone—asthma	2.45e-05	0.000161	CcSEcCtD
Bosentan—Syncope—Betamethasone—asthma	2.45e-05	0.000161	CcSEcCtD
Bosentan—Infection—Triamcinolone—asthma	2.45e-05	0.000161	CcSEcCtD
Bosentan—Hypotension—Hydrocortisone—asthma	2.44e-05	0.000161	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CXCL10—asthma	2.44e-05	0.000272	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ARG2—asthma	2.44e-05	0.000272	CbGpPWpGaD
Bosentan—Infection—Methylprednisolone—asthma	2.44e-05	0.00016	CcSEcCtD
Bosentan—Shock—Triamcinolone—asthma	2.42e-05	0.000159	CcSEcCtD
Bosentan—Insomnia—Prednisolone—asthma	2.42e-05	0.000159	CcSEcCtD
Bosentan—Shock—Methylprednisolone—asthma	2.42e-05	0.000159	CcSEcCtD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—asthma	2.41e-05	0.00027	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CYBA—asthma	2.41e-05	0.000269	CbGpPWpGaD
Bosentan—Nervous system disorder—Methylprednisolone—asthma	2.41e-05	0.000158	CcSEcCtD
Bosentan—Loss of consciousness—Dexamethasone—asthma	2.41e-05	0.000158	CcSEcCtD
Bosentan—Loss of consciousness—Betamethasone—asthma	2.41e-05	0.000158	CcSEcCtD
Bosentan—Paraesthesia—Prednisolone—asthma	2.4e-05	0.000158	CcSEcCtD
Bosentan—Tachycardia—Triamcinolone—asthma	2.4e-05	0.000158	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CCR4—asthma	2.4e-05	0.000268	CbGpPWpGaD
Bosentan—Mental disorder—Prednisone—asthma	2.4e-05	0.000158	CcSEcCtD
Bosentan—Tachycardia—Methylprednisolone—asthma	2.4e-05	0.000157	CcSEcCtD
Bosentan—Skin disorder—Methylprednisolone—asthma	2.39e-05	0.000157	CcSEcCtD
Bosentan—Malnutrition—Prednisone—asthma	2.38e-05	0.000157	CcSEcCtD
Bosentan—Erythema—Prednisone—asthma	2.38e-05	0.000157	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Hydrocortisone—asthma	2.38e-05	0.000156	CcSEcCtD
Bosentan—Hyperhidrosis—Triamcinolone—asthma	2.38e-05	0.000156	CcSEcCtD
Bosentan—Hyperhidrosis—Methylprednisolone—asthma	2.37e-05	0.000156	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—ADRB2—asthma	2.37e-05	0.000265	CbGpPWpGaD
Bosentan—Insomnia—Hydrocortisone—asthma	2.36e-05	0.000155	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—IL5—asthma	2.36e-05	0.000264	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PARP1—asthma	2.36e-05	0.000264	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT6—asthma	2.35e-05	0.000263	CbGpPWpGaD
Bosentan—Paraesthesia—Hydrocortisone—asthma	2.35e-05	0.000154	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—EDN1—asthma	2.33e-05	0.00026	CbGpPWpGaD
Bosentan—Anxiety—Dexamethasone—asthma	2.32e-05	0.000153	CcSEcCtD
Bosentan—Anxiety—Betamethasone—asthma	2.32e-05	0.000153	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CCL5—asthma	2.31e-05	0.000258	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2RB—asthma	2.31e-05	0.000258	CbGpPWpGaD
Bosentan—Discomfort—Betamethasone—asthma	2.3e-05	0.000151	CcSEcCtD
Bosentan—Discomfort—Dexamethasone—asthma	2.3e-05	0.000151	CcSEcCtD
Bosentan—Dyspepsia—Hydrocortisone—asthma	2.3e-05	0.000151	CcSEcCtD
Bosentan—Hypotension—Methylprednisolone—asthma	2.29e-05	0.000151	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—PDE4D—asthma	2.29e-05	0.000256	CbGpPWpGaD
Bosentan—Pain—Prednisolone—asthma	2.29e-05	0.00015	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—BDKRB2—asthma	2.28e-05	0.000254	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CSF2—asthma	2.28e-05	0.000254	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—POMC—asthma	2.28e-05	0.000254	CbGpPWpGaD
Bosentan—Decreased appetite—Hydrocortisone—asthma	2.27e-05	0.000149	CcSEcCtD
Bosentan—Gastrointestinal disorder—Hydrocortisone—asthma	2.26e-05	0.000148	CcSEcCtD
Bosentan—Fatigue—Hydrocortisone—asthma	2.25e-05	0.000148	CcSEcCtD
Bosentan—Vision blurred—Prednisone—asthma	2.25e-05	0.000148	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Triamcinolone—asthma	2.24e-05	0.000147	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—ITPR1—asthma	2.24e-05	0.00025	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Methylprednisolone—asthma	2.24e-05	0.000147	CcSEcCtD
Bosentan—Pain—Hydrocortisone—asthma	2.24e-05	0.000147	CcSEcCtD
Bosentan—Anaphylactic shock—Betamethasone—asthma	2.23e-05	0.000147	CcSEcCtD
Bosentan—Oedema—Betamethasone—asthma	2.23e-05	0.000147	CcSEcCtD
Bosentan—Anaphylactic shock—Dexamethasone—asthma	2.23e-05	0.000147	CcSEcCtD
Bosentan—Oedema—Dexamethasone—asthma	2.23e-05	0.000147	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—PDE4B—asthma	2.23e-05	0.000249	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—C5—asthma	2.23e-05	0.000249	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TACR1—asthma	2.23e-05	0.000249	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL8—asthma	2.23e-05	0.000249	CbGpPWpGaD
Bosentan—Insomnia—Triamcinolone—asthma	2.23e-05	0.000146	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	2.22e-05	0.000248	CbGpPWpGaD
Bosentan—Insomnia—Methylprednisolone—asthma	2.22e-05	0.000146	CcSEcCtD
Bosentan—Infection—Dexamethasone—asthma	2.22e-05	0.000146	CcSEcCtD
Bosentan—Infection—Betamethasone—asthma	2.22e-05	0.000146	CcSEcCtD
Bosentan—Paraesthesia—Triamcinolone—asthma	2.21e-05	0.000145	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—ADCY2—asthma	2.21e-05	0.000246	CbGpPWpGaD
Bosentan—Paraesthesia—Methylprednisolone—asthma	2.21e-05	0.000145	CcSEcCtD
Bosentan—Anaemia—Prednisone—asthma	2.2e-05	0.000145	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—IL3—asthma	2.2e-05	0.000245	CbGpPWpGaD
Bosentan—Shock—Dexamethasone—asthma	2.2e-05	0.000144	CcSEcCtD
Bosentan—Shock—Betamethasone—asthma	2.2e-05	0.000144	CcSEcCtD
Bosentan—Dyspnoea—Triamcinolone—asthma	2.19e-05	0.000144	CcSEcCtD
Bosentan—Nervous system disorder—Dexamethasone—asthma	2.19e-05	0.000144	CcSEcCtD
Bosentan—Nervous system disorder—Betamethasone—asthma	2.19e-05	0.000144	CcSEcCtD
Bosentan—Thrombocytopenia—Dexamethasone—asthma	2.19e-05	0.000144	CcSEcCtD
Bosentan—Thrombocytopenia—Betamethasone—asthma	2.19e-05	0.000144	CcSEcCtD
Bosentan—Tachycardia—Dexamethasone—asthma	2.18e-05	0.000143	CcSEcCtD
Bosentan—Tachycardia—Betamethasone—asthma	2.18e-05	0.000143	CcSEcCtD
Bosentan—Angioedema—Prednisone—asthma	2.18e-05	0.000143	CcSEcCtD
Bosentan—Dyspepsia—Triamcinolone—asthma	2.17e-05	0.000142	CcSEcCtD
Bosentan—Dyspepsia—Methylprednisolone—asthma	2.16e-05	0.000142	CcSEcCtD
Bosentan—Hyperhidrosis—Dexamethasone—asthma	2.16e-05	0.000142	CcSEcCtD
Bosentan—Hyperhidrosis—Betamethasone—asthma	2.16e-05	0.000142	CcSEcCtD
Bosentan—Vertigo—Prednisone—asthma	2.14e-05	0.000141	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.14e-05	0.000239	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Hydrocortisone—asthma	2.14e-05	0.00014	CcSEcCtD
Bosentan—Syncope—Prednisone—asthma	2.14e-05	0.00014	CcSEcCtD
Bosentan—Anorexia—Dexamethasone—asthma	2.13e-05	0.00014	CcSEcCtD
Bosentan—Anorexia—Betamethasone—asthma	2.13e-05	0.00014	CcSEcCtD
Bosentan—Urticaria—Prednisolone—asthma	2.13e-05	0.00014	CcSEcCtD
Bosentan—Fatigue—Triamcinolone—asthma	2.12e-05	0.000139	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—EDN1—asthma	2.12e-05	0.000236	CbGpPWpGaD
Bosentan—Fatigue—Methylprednisolone—asthma	2.12e-05	0.000139	CcSEcCtD
Bosentan—Pain—Triamcinolone—asthma	2.1e-05	0.000138	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CCL5—asthma	2.1e-05	0.000235	CbGpPWpGaD
Bosentan—Loss of consciousness—Prednisone—asthma	2.09e-05	0.000138	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—PLA2G4A—asthma	2.09e-05	0.000234	CbGpPWpGaD
Bosentan—Hypotension—Betamethasone—asthma	2.09e-05	0.000137	CcSEcCtD
Bosentan—Hypotension—Dexamethasone—asthma	2.09e-05	0.000137	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CCR5—asthma	2.08e-05	0.000233	CbGpPWpGaD
Bosentan—Urticaria—Hydrocortisone—asthma	2.08e-05	0.000136	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—KNG1—asthma	2.07e-05	0.000232	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CSF2—asthma	2.07e-05	0.000231	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—POMC—asthma	2.07e-05	0.000231	CbGpPWpGaD
Bosentan—Body temperature increased—Hydrocortisone—asthma	2.07e-05	0.000136	CcSEcCtD
Bosentan—Abdominal pain—Hydrocortisone—asthma	2.07e-05	0.000136	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—AGTR1—asthma	2.06e-05	0.00023	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2RA—asthma	2.05e-05	0.000229	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR3—asthma	2.04e-05	0.000228	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—C3—asthma	2.04e-05	0.000227	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Betamethasone—asthma	2.03e-05	0.000134	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Dexamethasone—asthma	2.03e-05	0.000134	CcSEcCtD
Bosentan—Arthralgia—Prednisone—asthma	2.03e-05	0.000133	CcSEcCtD
Bosentan—CYP3A4—Biological oxidations—ALDH2—asthma	2.03e-05	0.000226	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTP1—asthma	2.02e-05	0.000226	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL2—asthma	2.02e-05	0.000226	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALOX15—asthma	2.02e-05	0.000226	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALOX5AP—asthma	2.02e-05	0.000226	CbGpPWpGaD
Bosentan—Anxiety—Prednisone—asthma	2.02e-05	0.000133	CcSEcCtD
Bosentan—Insomnia—Betamethasone—asthma	2.02e-05	0.000133	CcSEcCtD
Bosentan—Insomnia—Dexamethasone—asthma	2.02e-05	0.000133	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—IL6R—asthma	2.02e-05	0.000225	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL10—asthma	2.02e-05	0.000225	CbGpPWpGaD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	2.01e-05	0.000132	CcSEcCtD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	2.01e-05	0.000225	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Methylprednisolone—asthma	2.01e-05	0.000132	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—RHOA—asthma	2.01e-05	0.000224	CbGpPWpGaD
Bosentan—Paraesthesia—Betamethasone—asthma	2.01e-05	0.000132	CcSEcCtD
Bosentan—Paraesthesia—Dexamethasone—asthma	2.01e-05	0.000132	CcSEcCtD
Bosentan—Discomfort—Prednisone—asthma	2e-05	0.000132	CcSEcCtD
Bosentan—CYP2C9—Metapathway biotransformation—GSTP1—asthma	2e-05	0.000223	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NPY—asthma	1.99e-05	0.000222	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NTRK1—asthma	1.98e-05	0.000221	CbGpPWpGaD
Bosentan—Hypersensitivity—Prednisolone—asthma	1.97e-05	0.00013	CcSEcCtD
Bosentan—Dyspepsia—Betamethasone—asthma	1.97e-05	0.000129	CcSEcCtD
Bosentan—Dyspepsia—Dexamethasone—asthma	1.97e-05	0.000129	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—ADRB2—asthma	1.96e-05	0.000218	CbGpPWpGaD
Bosentan—Urticaria—Triamcinolone—asthma	1.96e-05	0.000128	CcSEcCtD
Bosentan—Urticaria—Methylprednisolone—asthma	1.95e-05	0.000128	CcSEcCtD
Bosentan—Body temperature increased—Triamcinolone—asthma	1.95e-05	0.000128	CcSEcCtD
Bosentan—Oedema—Prednisone—asthma	1.94e-05	0.000128	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisone—asthma	1.94e-05	0.000128	CcSEcCtD
Bosentan—Abdominal pain—Methylprednisolone—asthma	1.94e-05	0.000128	CcSEcCtD
Bosentan—Decreased appetite—Betamethasone—asthma	1.94e-05	0.000128	CcSEcCtD
Bosentan—Decreased appetite—Dexamethasone—asthma	1.94e-05	0.000128	CcSEcCtD
Bosentan—Infection—Prednisone—asthma	1.93e-05	0.000127	CcSEcCtD
Bosentan—ABCB11—Metabolism—CHAT—asthma	1.93e-05	0.000215	CbGpPWpGaD
Bosentan—Gastrointestinal disorder—Dexamethasone—asthma	1.93e-05	0.000127	CcSEcCtD
Bosentan—Gastrointestinal disorder—Betamethasone—asthma	1.93e-05	0.000127	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—PPP2CA—asthma	1.93e-05	0.000215	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTT1—asthma	1.93e-05	0.000215	CbGpPWpGaD
Bosentan—Hypersensitivity—Hydrocortisone—asthma	1.93e-05	0.000127	CcSEcCtD
Bosentan—Fatigue—Betamethasone—asthma	1.93e-05	0.000127	CcSEcCtD
Bosentan—Fatigue—Dexamethasone—asthma	1.93e-05	0.000127	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—AGTR2—asthma	1.92e-05	0.000214	CbGpPWpGaD
Bosentan—Shock—Prednisone—asthma	1.91e-05	0.000126	CcSEcCtD
Bosentan—Pain—Betamethasone—asthma	1.91e-05	0.000125	CcSEcCtD
Bosentan—Pain—Dexamethasone—asthma	1.91e-05	0.000125	CcSEcCtD
Bosentan—Nervous system disorder—Prednisone—asthma	1.91e-05	0.000125	CcSEcCtD
Bosentan—Tachycardia—Prednisone—asthma	1.9e-05	0.000125	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CCR5—asthma	1.89e-05	0.000211	CbGpPWpGaD
Bosentan—Skin disorder—Prednisone—asthma	1.89e-05	0.000124	CcSEcCtD
Bosentan—Hyperhidrosis—Prednisone—asthma	1.88e-05	0.000124	CcSEcCtD
Bosentan—Asthenia—Hydrocortisone—asthma	1.88e-05	0.000123	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—IL2RA—asthma	1.87e-05	0.000208	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTM1—asthma	1.86e-05	0.000208	CbGpPWpGaD
Bosentan—Anorexia—Prednisone—asthma	1.85e-05	0.000122	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—ITPR1—asthma	1.85e-05	0.000207	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—C3—asthma	1.85e-05	0.000207	CbGpPWpGaD
Bosentan—Pruritus—Hydrocortisone—asthma	1.85e-05	0.000122	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—EDNRB—asthma	1.84e-05	0.000205	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTM1—asthma	1.84e-05	0.000205	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Dexamethasone—asthma	1.83e-05	0.00012	CcSEcCtD
Bosentan—Gastrointestinal pain—Betamethasone—asthma	1.83e-05	0.00012	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—RHOA—asthma	1.82e-05	0.000203	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NPS—asthma	1.82e-05	0.000203	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TAC1—asthma	1.82e-05	0.000203	CbGpPWpGaD
Bosentan—Hypersensitivity—Triamcinolone—asthma	1.81e-05	0.000119	CcSEcCtD
Bosentan—Hypersensitivity—Methylprednisolone—asthma	1.81e-05	0.000119	CcSEcCtD
Bosentan—Diarrhoea—Hydrocortisone—asthma	1.79e-05	0.000118	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CXCR3—asthma	1.78e-05	0.000199	CbGpPWpGaD
Bosentan—Urticaria—Betamethasone—asthma	1.77e-05	0.000117	CcSEcCtD
Bosentan—Urticaria—Dexamethasone—asthma	1.77e-05	0.000117	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Prednisone—asthma	1.77e-05	0.000116	CcSEcCtD
Bosentan—Dizziness—Prednisolone—asthma	1.77e-05	0.000116	CcSEcCtD
Bosentan—Asthenia—Triamcinolone—asthma	1.77e-05	0.000116	CcSEcCtD
Bosentan—Abdominal pain—Betamethasone—asthma	1.77e-05	0.000116	CcSEcCtD
Bosentan—Abdominal pain—Dexamethasone—asthma	1.77e-05	0.000116	CcSEcCtD
Bosentan—Body temperature increased—Betamethasone—asthma	1.77e-05	0.000116	CcSEcCtD
Bosentan—Body temperature increased—Dexamethasone—asthma	1.77e-05	0.000116	CcSEcCtD
Bosentan—Asthenia—Methylprednisolone—asthma	1.76e-05	0.000116	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CD86—asthma	1.76e-05	0.000197	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL8—asthma	1.76e-05	0.000197	CbGpPWpGaD
Bosentan—Insomnia—Prednisone—asthma	1.76e-05	0.000116	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—EDN1—asthma	1.75e-05	0.000195	CbGpPWpGaD
Bosentan—Paraesthesia—Prednisone—asthma	1.75e-05	0.000115	CcSEcCtD
Bosentan—Pruritus—Triamcinolone—asthma	1.74e-05	0.000114	CcSEcCtD
Bosentan—Pruritus—Methylprednisolone—asthma	1.74e-05	0.000114	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CCL5—asthma	1.73e-05	0.000194	CbGpPWpGaD
Bosentan—Dizziness—Hydrocortisone—asthma	1.73e-05	0.000114	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—PLA2G4A—asthma	1.73e-05	0.000193	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CYBA—asthma	1.73e-05	0.000193	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALOX5—asthma	1.72e-05	0.000192	CbGpPWpGaD
Bosentan—Dyspepsia—Prednisone—asthma	1.71e-05	0.000112	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CSF2—asthma	1.71e-05	0.000191	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PARP1—asthma	1.69e-05	0.000189	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL5—asthma	1.69e-05	0.000189	CbGpPWpGaD
Bosentan—Decreased appetite—Prednisone—asthma	1.69e-05	0.000111	CcSEcCtD
Bosentan—Rash—Prednisolone—asthma	1.69e-05	0.000111	CcSEcCtD
Bosentan—Dermatitis—Prednisolone—asthma	1.69e-05	0.000111	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—IL2—asthma	1.68e-05	0.000188	CbGpPWpGaD
Bosentan—Diarrhoea—Methylprednisolone—asthma	1.68e-05	0.00011	CcSEcCtD
Bosentan—Fatigue—Prednisone—asthma	1.68e-05	0.00011	CcSEcCtD
Bosentan—Headache—Prednisolone—asthma	1.68e-05	0.00011	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—SMAD3—asthma	1.66e-05	0.000186	CbGpPWpGaD
Bosentan—Constipation—Prednisone—asthma	1.66e-05	0.000109	CcSEcCtD
Bosentan—Vomiting—Hydrocortisone—asthma	1.66e-05	0.000109	CcSEcCtD
Bosentan—Rash—Hydrocortisone—asthma	1.65e-05	0.000108	CcSEcCtD
Bosentan—Dermatitis—Hydrocortisone—asthma	1.65e-05	0.000108	CcSEcCtD
Bosentan—ABCB11—Metabolism—CARM1—asthma	1.64e-05	0.000183	CbGpPWpGaD
Bosentan—Headache—Hydrocortisone—asthma	1.64e-05	0.000108	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	1.63e-05	0.000182	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BDKRB2—asthma	1.63e-05	0.000182	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—POMC—asthma	1.63e-05	0.000182	CbGpPWpGaD
Bosentan—Dizziness—Triamcinolone—asthma	1.63e-05	0.000107	CcSEcCtD
Bosentan—Dizziness—Methylprednisolone—asthma	1.62e-05	0.000107	CcSEcCtD
Bosentan—ABCB11—Metabolism—DCN—asthma	1.62e-05	0.00018	CbGpPWpGaD
Bosentan—Asthenia—Betamethasone—asthma	1.6e-05	0.000105	CcSEcCtD
Bosentan—Asthenia—Dexamethasone—asthma	1.6e-05	0.000105	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CXCL8—asthma	1.6e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PPP2CA—asthma	1.59e-05	0.000178	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Prednisone—asthma	1.59e-05	0.000105	CcSEcCtD
Bosentan—Nausea—Prednisolone—asthma	1.59e-05	0.000104	CcSEcCtD
Bosentan—Pruritus—Betamethasone—asthma	1.58e-05	0.000104	CcSEcCtD
Bosentan—Pruritus—Dexamethasone—asthma	1.58e-05	0.000104	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—ADCY2—asthma	1.58e-05	0.000176	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL3—asthma	1.57e-05	0.000176	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALDH2—asthma	1.57e-05	0.000176	CbGpPWpGaD
Bosentan—Vomiting—Triamcinolone—asthma	1.57e-05	0.000103	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CCR5—asthma	1.56e-05	0.000174	CbGpPWpGaD
Bosentan—Vomiting—Methylprednisolone—asthma	1.56e-05	0.000103	CcSEcCtD
Bosentan—Nausea—Hydrocortisone—asthma	1.55e-05	0.000102	CcSEcCtD
Bosentan—Rash—Triamcinolone—asthma	1.55e-05	0.000102	CcSEcCtD
Bosentan—Dermatitis—Triamcinolone—asthma	1.55e-05	0.000102	CcSEcCtD
Bosentan—Rash—Methylprednisolone—asthma	1.55e-05	0.000102	CcSEcCtD
Bosentan—Dermatitis—Methylprednisolone—asthma	1.55e-05	0.000102	CcSEcCtD
Bosentan—Urticaria—Prednisone—asthma	1.55e-05	0.000102	CcSEcCtD
Bosentan—Headache—Triamcinolone—asthma	1.54e-05	0.000101	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—IL2RA—asthma	1.54e-05	0.000172	CbGpPWpGaD
Bosentan—Headache—Methylprednisolone—asthma	1.54e-05	0.000101	CcSEcCtD
Bosentan—Abdominal pain—Prednisone—asthma	1.54e-05	0.000101	CcSEcCtD
Bosentan—Body temperature increased—Prednisone—asthma	1.54e-05	0.000101	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—IL2—asthma	1.53e-05	0.000171	CbGpPWpGaD
Bosentan—Diarrhoea—Betamethasone—asthma	1.53e-05	0.0001	CcSEcCtD
Bosentan—Diarrhoea—Dexamethasone—asthma	1.53e-05	0.0001	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—C3—asthma	1.53e-05	0.00017	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	1.52e-05	0.000169	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	1.52e-05	0.000169	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—POMC—asthma	1.51e-05	0.000169	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTT1—asthma	1.5e-05	0.000167	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PDGFB—asthma	1.49e-05	0.000166	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KNG1—asthma	1.48e-05	0.000166	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—POMC—asthma	1.48e-05	0.000165	CbGpPWpGaD
Bosentan—Dizziness—Dexamethasone—asthma	1.48e-05	9.7e-05	CcSEcCtD
Bosentan—Dizziness—Betamethasone—asthma	1.48e-05	9.7e-05	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—AGTR1—asthma	1.48e-05	0.000165	CbGpPWpGaD
Bosentan—Nausea—Triamcinolone—asthma	1.46e-05	9.61e-05	CcSEcCtD
Bosentan—Nausea—Methylprednisolone—asthma	1.46e-05	9.59e-05	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CCL2—asthma	1.45e-05	0.000162	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	1.45e-05	0.000161	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6R—asthma	1.44e-05	0.000161	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL10—asthma	1.44e-05	0.000161	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—RHOA—asthma	1.44e-05	0.00016	CbGpPWpGaD
Bosentan—Hypersensitivity—Prednisone—asthma	1.43e-05	9.42e-05	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—LEP—asthma	1.42e-05	0.000159	CbGpPWpGaD
Bosentan—Vomiting—Betamethasone—asthma	1.42e-05	9.33e-05	CcSEcCtD
Bosentan—Vomiting—Dexamethasone—asthma	1.42e-05	9.33e-05	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—NTRK1—asthma	1.41e-05	0.000158	CbGpPWpGaD
Bosentan—Rash—Dexamethasone—asthma	1.41e-05	9.25e-05	CcSEcCtD
Bosentan—Rash—Betamethasone—asthma	1.41e-05	9.25e-05	CcSEcCtD
Bosentan—Dermatitis—Betamethasone—asthma	1.41e-05	9.24e-05	CcSEcCtD
Bosentan—Dermatitis—Dexamethasone—asthma	1.41e-05	9.24e-05	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—ADRB2—asthma	1.4e-05	0.000156	CbGpPWpGaD
Bosentan—Headache—Dexamethasone—asthma	1.4e-05	9.19e-05	CcSEcCtD
Bosentan—Headache—Betamethasone—asthma	1.4e-05	9.19e-05	CcSEcCtD
Bosentan—Asthenia—Prednisone—asthma	1.4e-05	9.17e-05	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—asthma	1.38e-05	0.000154	CbGpPWpGaD
Bosentan—Pruritus—Prednisone—asthma	1.38e-05	9.04e-05	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—FN1—asthma	1.34e-05	0.00015	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTP1—asthma	1.34e-05	0.000149	CbGpPWpGaD
Bosentan—Diarrhoea—Prednisone—asthma	1.33e-05	8.74e-05	CcSEcCtD
Bosentan—Nausea—Dexamethasone—asthma	1.33e-05	8.72e-05	CcSEcCtD
Bosentan—Nausea—Betamethasone—asthma	1.33e-05	8.72e-05	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—ITPR1—asthma	1.32e-05	0.000148	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.32e-05	0.000147	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—POMC—asthma	1.32e-05	0.000147	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—RHOA—asthma	1.3e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.29e-05	0.000144	CbGpPWpGaD
Bosentan—Dizziness—Prednisone—asthma	1.29e-05	8.45e-05	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CD86—asthma	1.26e-05	0.000141	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL8—asthma	1.26e-05	0.000141	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EDN1—asthma	1.25e-05	0.00014	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NQO1—asthma	1.24e-05	0.000139	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL5—asthma	1.24e-05	0.000139	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LTC4S—asthma	1.24e-05	0.000138	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PLA2G4A—asthma	1.24e-05	0.000138	CbGpPWpGaD
Bosentan—Vomiting—Prednisone—asthma	1.24e-05	8.13e-05	CcSEcCtD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	1.23e-05	0.000137	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTM1—asthma	1.23e-05	0.000137	CbGpPWpGaD
Bosentan—Rash—Prednisone—asthma	1.23e-05	8.06e-05	CcSEcCtD
Bosentan—Dermatitis—Prednisone—asthma	1.23e-05	8.05e-05	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CSF2—asthma	1.22e-05	0.000136	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—POMC—asthma	1.22e-05	0.000136	CbGpPWpGaD
Bosentan—Headache—Prednisone—asthma	1.22e-05	8.01e-05	CcSEcCtD
Bosentan—ABCB11—Metabolism—ADCY2—asthma	1.22e-05	0.000136	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.21e-05	0.000135	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.21e-05	0.000135	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—asthma	1.2e-05	0.000134	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL2—asthma	1.2e-05	0.000133	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6R—asthma	1.19e-05	0.000133	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SMAD3—asthma	1.19e-05	0.000133	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EGFR—asthma	1.17e-05	0.00013	CbGpPWpGaD
Bosentan—Nausea—Prednisone—asthma	1.16e-05	7.59e-05	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—asthma	1.14e-05	0.000128	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PPP2CA—asthma	1.14e-05	0.000127	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR5—asthma	1.12e-05	0.000125	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SERPINE1—asthma	1.12e-05	0.000125	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2RA—asthma	1.1e-05	0.000123	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—asthma	1.09e-05	0.000122	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—C3—asthma	1.09e-05	0.000122	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RHOA—asthma	1.08e-05	0.00012	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LTA4H—asthma	1.08e-05	0.00012	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOS3—asthma	1.07e-05	0.000119	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PDGFB—asthma	1.06e-05	0.000119	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTEN—asthma	1.05e-05	0.000117	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTP1—asthma	1.04e-05	0.000116	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMOX1—asthma	1.02e-05	0.000114	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ITPR1—asthma	1.02e-05	0.000114	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LEP—asthma	1.02e-05	0.000114	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAT—asthma	1.01e-05	0.000113	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FN1—asthma	9.6e-06	0.000107	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PLA2G4A—asthma	9.53e-06	0.000106	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTM1—asthma	9.53e-06	0.000106	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—asthma	9.45e-06	0.000105	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ARG1—asthma	9.4e-06	0.000105	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—asthma	9.03e-06	0.000101	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—asthma	8.98e-06	0.0001	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPP2CA—asthma	8.78e-06	9.8e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—POMC—asthma	8.74e-06	9.76e-05	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—POMC—asthma	8.67e-06	9.68e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL2—asthma	8.55e-06	9.55e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—asthma	8.55e-06	9.54e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6R—asthma	8.53e-06	9.52e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDH7A1—asthma	8.5e-06	9.49e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PTEN—asthma	8.5e-06	9.48e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EGFR—asthma	8.37e-06	9.34e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LTC4S—asthma	8.18e-06	9.13e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ARG2—asthma	8.15e-06	9.1e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SERPINE1—asthma	7.98e-06	8.91e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RHOA—asthma	7.7e-06	8.6e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—asthma	7.67e-06	8.56e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOS3—asthma	7.62e-06	8.51e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—asthma	7.6e-06	8.48e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	7.15e-06	7.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LTA4H—asthma	7.09e-06	7.92e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TGFB1—asthma	7.04e-06	7.86e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGFR—asthma	6.91e-06	7.71e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—asthma	6.76e-06	7.55e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALOX5AP—asthma	6.75e-06	7.54e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALOX15—asthma	6.75e-06	7.54e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—POMC—asthma	6.74e-06	7.52e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—asthma	6.46e-06	7.21e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CHAT—asthma	6.44e-06	7.19e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—asthma	6.43e-06	7.18e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ARG1—asthma	6.2e-06	6.92e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—asthma	6.14e-06	6.85e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—asthma	6.12e-06	6.83e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PTEN—asthma	6.08e-06	6.79e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NOS3—asthma	5.87e-06	6.56e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALOX5—asthma	5.74e-06	6.41e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDH7A1—asthma	5.61e-06	6.26e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—asthma	5.49e-06	6.13e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CARM1—asthma	5.48e-06	6.11e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—asthma	5.44e-06	6.07e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—DCN—asthma	5.4e-06	6.03e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ARG2—asthma	5.38e-06	6e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—asthma	5.37e-06	6e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—asthma	5.31e-06	5.92e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDH2—asthma	5.25e-06	5.86e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	5.05e-06	5.64e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TGFB1—asthma	5.04e-06	5.63e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTT1—asthma	5e-06	5.58e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGFR—asthma	4.94e-06	5.52e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTEN—asthma	4.69e-06	5.23e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	4.6e-06	5.14e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALOX5AP—asthma	4.45e-06	4.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALOX15—asthma	4.45e-06	4.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CHAT—asthma	4.25e-06	4.74e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NQO1—asthma	4.15e-06	4.63e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADCY2—asthma	4.06e-06	4.53e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.03e-06	4.5e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—asthma	3.8e-06	4.24e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALOX5—asthma	3.79e-06	4.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CARM1—asthma	3.61e-06	4.03e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—DCN—asthma	3.56e-06	3.97e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	3.51e-06	3.92e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDH2—asthma	3.46e-06	3.87e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTP1—asthma	3.46e-06	3.86e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMOX1—asthma	3.41e-06	3.81e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ITPR1—asthma	3.41e-06	3.8e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAT—asthma	3.37e-06	3.76e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTT1—asthma	3.29e-06	3.68e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—asthma	3.18e-06	3.55e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLA2G4A—asthma	3.18e-06	3.55e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPP2CA—asthma	2.93e-06	3.27e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NQO1—asthma	2.74e-06	3.06e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADCY2—asthma	2.68e-06	2.99e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTP1—asthma	2.28e-06	2.55e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMOX1—asthma	2.25e-06	2.51e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—POMC—asthma	2.25e-06	2.51e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ITPR1—asthma	2.25e-06	2.51e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAT—asthma	2.22e-06	2.48e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLA2G4A—asthma	2.1e-06	2.34e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—asthma	2.1e-06	2.34e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—asthma	2.05e-06	2.29e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NOS3—asthma	1.96e-06	2.19e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPP2CA—asthma	1.93e-06	2.16e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—asthma	1.79e-06	2e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTEN—asthma	1.56e-06	1.75e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—POMC—asthma	1.48e-06	1.66e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—asthma	1.35e-06	1.51e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NOS3—asthma	1.29e-06	1.44e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—asthma	1.18e-06	1.32e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTEN—asthma	1.03e-06	1.15e-05	CbGpPWpGaD
